bepridil has been researched along with sq-11725 in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (50.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Topliss, JG; Yoshida, F | 1 |
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Humen, DP; Jablonsky, G; Kostuk, WJ; O'Brien, PA; Pflugfelder, PW; Purves, PD | 1 |
1 trial(s) available for bepridil and sq-11725
Article | Year |
---|---|
Comparison of bepridil with nadolol for angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Angiography; Bepridil; Clinical Trials as Topic; Drug Administration Schedule; Electrocardiography; Exercise Test; Female; Heart; Heart Ventricles; Humans; Male; Middle Aged; Nadolol; Pyrrolidines; Radionuclide Imaging | 1987 |
3 other study(ies) available for bepridil and sq-11725
Article | Year |
---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |